167 related articles for article (PubMed ID: 10472350)
21. Paclitaxel-Based chemotherapy for non-small cell lung cancer: predicting the response with 99mTc-tetrofosmin chest imaging.
Kao CH; Hsieh JF; Tsai SC; Ho YJ; Changlai SP; Lee JK
J Nucl Med; 2001 Jan; 42(1):17-20. PubMed ID: 11197970
[TBL] [Abstract][Full Text] [Related]
22. Quickly predicting chemotherapy response to paclitaxel-based therapy in non-small cell lung cancer by early technetium-99m methoxyisobutylisonitrile chest single-photon-emission computed tomography.
Kao CH; Hsieh JF; Tsai SC; Ho YJ; Lee JK
Clin Cancer Res; 2000 Mar; 6(3):820-4. PubMed ID: 10741702
[TBL] [Abstract][Full Text] [Related]
23. Increased uptake of the apoptosis-imaging agent (99m)Tc recombinant human Annexin V in human tumors after one course of chemotherapy as a predictor of tumor response and patient prognosis.
Belhocine T; Steinmetz N; Hustinx R; Bartsch P; Jerusalem G; Seidel L; Rigo P; Green A
Clin Cancer Res; 2002 Sep; 8(9):2766-74. PubMed ID: 12231515
[TBL] [Abstract][Full Text] [Related]
24. Usefulness of chest single photon emission computed tomography with technetium-99m methoxyisobutylisonitrile to predict taxol based chemotherapy response in advanced non-small cell lung cancer.
Shih CM; Hsu WH; Huang WT; Wang JJ; Ho ST; Kao A
Cancer Lett; 2003 Sep; 199(1):99-105. PubMed ID: 12963129
[TBL] [Abstract][Full Text] [Related]
25. Technetium-99m-hexakis-2-methoxyisobutylisonitrile scintigraphy and multidrug resistance-related protein expression in human primary lung cancer.
Duan XY; Wang JS; Liu M; Guo YM
Ann Nucl Med; 2008 Jan; 22(1):49-55. PubMed ID: 18250987
[TBL] [Abstract][Full Text] [Related]
26. Tetrofosmin as predictors of tumour response.
Fuster D; Viñolas N; Mallafré C; Pavia J; Martín F; Pons F
Q J Nucl Med; 2003 Mar; 47(1):58-62. PubMed ID: 12714956
[TBL] [Abstract][Full Text] [Related]
27. Detecting mediastinal lymph node metastases in non-small-cell lung cancer using a combination of technetium-99m tetrofosmin chest single photon emission computed tomography and chest computed tomography.
Shiun SC; Sun SS; Hsu NY; Kao CH; Lin CC; Lee CC
Cancer Invest; 2002; 20(3):311-7. PubMed ID: 12025225
[TBL] [Abstract][Full Text] [Related]
28. Technetium-99m-tetrofosmin SPECT imaging of lung masses: a negative study.
Kao CH; ChangLai SP; Shen YY; Lee JK; Wang SJ
J Nucl Med; 1997 Jul; 38(7):1015-9. PubMed ID: 9225781
[TBL] [Abstract][Full Text] [Related]
29. Comparative study of technetium-99m-sestamibi and thallium-201 SPECT in predicting chemotherapeutic response in small cell lung cancer.
Yamamoto Y; Nishiyama Y; Satoh K; Takashima H; Ohkawa M; Fujita J; Kishi T; Matsuno S; Tanabe M
J Nucl Med; 1998 Sep; 39(9):1626-9. PubMed ID: 9744357
[TBL] [Abstract][Full Text] [Related]
30. Dipyridamole modulated Tc-99m sestamibi lung SPECT in small cell lung cancer.
Bom HS; Lim SC; Kim YC; Song HC; Min JJ; Jeong HJ; Kim JY; Lee J; Park KO
Clin Nucl Med; 1999 Feb; 24(2):97-101. PubMed ID: 9988065
[TBL] [Abstract][Full Text] [Related]
31. [Study of pulmonary lesions with (99m)Tc-Tetrafosmin and chest spect. Determination of uptake related factors, diagnostic value and prognosis].
Tabuenca MJ; Vargas JA; Castejón R; Varela A; Salas C; Ramón Y Cajal S; Durántez A; Ortiz-Berrocal J
Rev Esp Med Nucl; 2002 Apr; 21(2):99-108. PubMed ID: 11879618
[TBL] [Abstract][Full Text] [Related]
32. Technetium-99m-tetrofosmin scintigraphy in patients with metastatic soft tissue sarcoma.
Karanikas G; Köstler WJ; Becherer A; Wiesner K; Dudczak R; Krainer M; Kletter K
Oncol Rep; 2002; 9(5):1009-13. PubMed ID: 12168065
[TBL] [Abstract][Full Text] [Related]
33. Technetium-99m-tetrofosmin scintigraphy in the prediction of chemotherapy response of untreated malignant lymphomas and comparison with other prognostic factors.
Sun SS; Tsai SC; Wang JJ; Ho YJ; Ho ST; Kao CH
Anticancer Res; 2001; 21(1B):685-8. PubMed ID: 11299826
[TBL] [Abstract][Full Text] [Related]
34. The clinical usefulness of (99m)Tc-Tetrofosmin scintigraphy in the diagnosis of lung neoplasmas and mediastinal lymphoid node involvement.
Huang D; Zhao F; Zhang Y
J Huazhong Univ Sci Technolog Med Sci; 2008 Oct; 28(5):608-12. PubMed ID: 18846350
[TBL] [Abstract][Full Text] [Related]
35. Comparison of chemotherapy response with P-glycoprotein, multidrug resistance-related protein-1, and lung resistance-related protein expression in untreated small cell lung cancer.
Yeh JJ; Hsu NY; Hsu WH; Tsai CH; Lin CC; Liang JA
Lung; 2005; 183(3):177-83. PubMed ID: 16078039
[TBL] [Abstract][Full Text] [Related]
36. Predicting chemotherapy response and comparing with P-glycoprotein expression using technetium-99m tetrofosmin scan in untreated malignant lymphomas.
Shiau YC; Tsai SC; Wang JJ; Ho YJ; Ho ST; Kao CH
Cancer Lett; 2001 Sep; 170(2):139-46. PubMed ID: 11463491
[TBL] [Abstract][Full Text] [Related]
37. [Correlation between 99m Tc-tetrofosmin uptake and P-glycoprotein expression in non-small-cell lung cancer].
Tabuenca MJ; Vargas JA; Varela A; Salas C; Durántez A; Ortiz Berrocal J
Rev Esp Med Nucl; 1998; 17(6):427-34. PubMed ID: 9873130
[TBL] [Abstract][Full Text] [Related]
38. Monitoring the chemotherapeutic response in primary lung cancer using 99mTc-MIBI SPET.
Yüksel M; Cermik TF; Karlikaya C; Salan A; Cakir E; Gültekin A; Berkarda S
Eur J Nucl Med; 2001 Jul; 28(7):799-806. PubMed ID: 11504075
[TBL] [Abstract][Full Text] [Related]
39. 99mTc tetrofosmin scintigraphy in acute leukaemia: the relationship between marrow uptake of tetrofosmin and P-glycoprotein and chemotherapy response.
Sükan A; Yapar Z; SAhin B; Kara O; Fuat Yapar A; CEtiner S; Kibar M
Nucl Med Commun; 2004 Aug; 25(8):777-85. PubMed ID: 15266171
[TBL] [Abstract][Full Text] [Related]
40. Semi-quantitative assessment of 99Tcm-sestamibi uptake in lung cancer: relationship with clinical response to chemotherapy.
Ceriani L; Giovanella L; Bandera M; Beghe B; Ortelli M; Roncari G
Nucl Med Commun; 1997 Nov; 18(11):1087-97. PubMed ID: 9423210
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
